Number Of NuvaRing Lawsuits Filed Against Merck Increases, And New Evidence That NuvaRing Causes Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), And Blood Clots
Judge Rodney Sippel's October 8, 2013 Order Rescheduling First NuvaRing MDL Trial
The trial date for the Prather case has been reset and will now be April 7, 2014.
The Prather v. Organon case, 4:08 CV 558 RWS, which had been set to start trial in October 2013 has been rescheduled. The Prather NuvaRing trial will now be held on January 27, 2014, according to this latest Order by Judge Sippel.
From the conclusion of this same July 2013 Order:
IT IS FURTHER ORDERED that the parties are ordered to maintain regular and frequent contact with the mediator who will report the status of any negotiations to the Court.
UPDATE: "Mo. Federal Judge Denies Organon Summary Judgment on NuvaRing Punitive Damages Claim" (July 17, 2013, HarrisMartin Publishing -- subscription required)
ST. LOUIS — A Missouri federal judge has denied Organon USA Inc.’s motion for summary judgment on a NuvaRing plaintiff’s punitive damages claim, finding the device's label does not foreclose punitive damages because it does not explicitly warn of the difference in risk of venous thromboembolism and pulmonary embolism.
On July 12, Judge Rodney W. Sippel of the U.S. District Court for the Eastern District of Missouri also rejected Organon’s assertion that New Jersey, rather than Missouri, law applies to the claim.
Marianne Prather sued Organon, alleging injuries caused by NuvaRing, a combined hormonal contraceptive. NuvaRing is a flexible ring ...
UPDATE: The NuvaRing bellwether case trial in the New Jersey state court consolidated NuvaRing litigation which was scheduled to start on June 17, 2013 was CANCELLED due to adverse rulings made by New Jersey Judge Brian Martinotti in April 2013.
During the past year we have reported periodically on the NuvaRing drug injury lawsuits -- both the federal court NuvaRing MDL pending before Judge Rodney Sippel and the New Jersey state court consolidated NuvaRing litigation being handled by Judge Brian Martinotti -- as well as medical studies that link Merck's NuvaRing vaginal ring to an increased risk of blood clots that can cause deep vein thrombosis (DVT) and/or pulmonary embolism (PE), some of which resulted in the death of a woman or a girl.
We present this round-up of those Drug Injury Watch articles, now, in order to put in front of you the various reports of significant developments.
Articles About NuvaRing Lawsuits 2012 - 2013:
Free NuvaRing Case Evaluation
Strictly Confidential, No Obligation.
Articles About NuvaRing Blood Clot-Related Side Effects Such As PEs, DVTs, Strokes, Heart Attacks:
Of course, we will continue to monitor both the legal and medical aspects of the NuvaRing lawsuits being filed on behalf of women and girls who have suffered a pulmonary embolism (PE), deep vein thrombosis (DVT), or some other blood clot-related condition. e.g., stroke or heart attack, resulting in serious injury or death.